Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Latest Press Releases
2018/04/19Adocia announces the release of its Reference Document for the year 2017
2018/04/16Number of shares and voting rights of ADOCIA as of March, 31 2018
May 14-20, 2018 AACE 2018 – 27th scientific and Clinical congress, Boston, (MA) USA - The 27th Annual AACE Scientific & Clinical Congress is one of the most important gatherings of clinical endocrinologists and other health care professionals who come together in their quest to learn more about the latest developments, research, devices and translational therapies needed to care for patients with diabetes, thyroid dysfunction, osteoporosis, obesity and other metabolic conditions.